We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.78B
AUM Growth
-$305M
Cap. Flow
-$1.04B
Cap. Flow %
-15.36%
Top 10 Hldgs %
29.21%
Holding
1,363
New
346
Increased
312
Reduced
313
Closed
357

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$251M
2
AGN
Allergan plc
AGN
+$209M
3
CI icon
Cigna
CI
+$106M
4
ESPR
Esperion Therapeutics
ESPR
+$77.7M
5
LH icon
Labcorp
LH
+$52.1M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$368M
2
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$354M
3
ENDP
Endo International plc
ENDP
+$331M
4
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$224M
5
BKD icon
Brookdale Senior Living
BKD
+$155M

Sector Composition

Rank Sector Weight
1 Healthcare 49.37%
2 Consumer Discretionary 6.42%
3 Industrials 5.53%
4 Financials 5.32%
5 Technology 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$435M 6.42%
1,462,409
+734,012
+101% +$209M
LH icon
2
Labcorp
LH
$25.4B
$409M 6.03%
3,774,065
+506,510
+16% +$52.1M
PRGO icon
3
Perrigo
PRGO
$1.4B
$331M 4.88%
1,998,556
+1,575,663
+373% +$251M
ENDP
4
DELISTED
Endo International plc
ENDP
$156M 2.3%
1,740,689
-3,960,062
-69% -$331M
ESPR
5
DELISTED
Esperion Therapeutics
ESPR
$130M 1.92%
1,403,600
+1,203,600
+602% +$77.7M
NBIX icon
6
Neurocrine Biosciences
NBIX
$16.8B
$120M 1.77%
3,019,877
+558,037
+23% +$20M
CI icon
7
Cigna
CI
$73.8B
$119M 1.76%
921,123
+914,133
+13,078% +$106M
ELV icon
8
Elevance Health
ELV
$81.5B
$117M 1.73%
760,227
+120,395
+19% +$17.1M
WMGI
9
DELISTED
Wright Medical Group Inc
WMGI
$82.7M 1.22%
3,205,495
+1,872,464
+140% +$48.2M
CNMD icon
10
CONMED
CNMD
$1.39B
$79.6M 1.17%
1,576,868
-333,736
-17% -$16.4M
HZNP
11
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$76.9M 1.13%
2,960,546
-1,531,978
-34% -$28.1M
BMRN icon
12
BioMarin Pharmaceuticals
BMRN
$11.6B
$72.8M 1.07%
584,503
-403,888
-41% -$42.8M
HR icon
13
Healthcare Realty
HR
$7.28B
$72.2M 1.06%
2,590,650
-75,392
-3% -$2.12M
ZBH icon
14
Zimmer Biomet
ZBH
$18.2B
$62.7M 0.93%
549,957
-223,582
-29% -$25.5M
RCPT
15
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$62.7M 0.92%
380,207
-254,375
-40% -$32.2M
YHOO
16
DELISTED
Yahoo Inc
YHOO
$53.3M 0.79%
1,199,857
+799,081
+199% +$36.1M
CLVS
17
DELISTED
Clovis Oncology, Inc.
CLVS
$48.8M 0.72%
656,992
-270,847
-29% -$19.1M
RARE icon
18
Ultragenyx Pharmaceutical
RARE
$2.45B
$45.8M 0.68%
737,496
-25,906
-3% -$1.44M
UNP icon
19
Union Pacific
UNP
$174B
$45.6M 0.67%
421,396
+249,931
+146% +$29.3M
SKX
20
DELISTED
Skechers
SKX
$45.6M 0.67%
1,903,581
+110,247
+6% +$2.37M
XL
21
DELISTED
XL Group Ltd.
XL
$44.8M 0.66%
1,217,534
+189,433
+18% +$6.79M
MDT icon
22
Medtronic
MDT
$109B
$44.4M 0.65%
569,079
+10,437
+2% +$791K
ALGN icon
23
Align Technology
ALGN
$12.1B
$44.3M 0.65%
823,900
+297,947
+57% +$17M
KND
24
DELISTED
Kindred Healthcare
KND
$43.2M 0.64%
1,814,342
+729,985
+67% +$14.8M
AAL icon
25
American Airlines Group
AAL
$10.1B
$42.5M 0.63%
805,153
+186,075
+30% +$9.45M
1
2 3 4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q1 2015 Portfolio in Review

As of Q1 2015, Visium Asset Management held 1,363 positions worth $6.78B, down 4.3% from $7.08B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Visium Asset Management withdrew a net $1.04B in Q1 2015, closing 357 positions and reducing 313 holdings. Its most notable exit was Allergan Inc, an estimated $368M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 47% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Visium Asset Management opened a new position in Akorn Inc worth $25.3M.

  • Visium Asset Management's largest Q1 2015 buy was Akorn Inc: 533,000 shares worth $25.3M.
  • Visium Asset Management added most to Perrigo in Q1 2015, an estimated $251M increase.
  • Visium Asset Management's biggest Q1 2015 reduction was Endo International plc, cutting an estimated $331M.
  • Visium Asset Management fully exited Allergan Inc in Q1 2015, selling an estimated $368M.
  • Visium Asset Management's ten largest holdings make up 29% of its $6.78B portfolio in Q1 2015.
  • Visium Asset Management opened 346 new positions and closed 357 in Q1 2015.
  • Visium Asset Management's portfolio value fell 4.3% quarter-over-quarter to $6.78B.

Based on Visium Asset Management's 13F filing for Q1 2015, filed 15 May 2015.